Updated the anti-corruption policy for one of the world's oldest pharmaceutical companies

The team of our practice successfully implemented a project aimed at updating the anti-corruption policy of a major pharmaceutical company. Our lawyers were to bring the current policy in line with current Russian legislation (taking into account court and law enforcement practice), the FCPA, the UK Bribery Act and the global anti-corruption standard of the parent company. In addition, the updated policy should describe in an accessible manner the requirements, restrictions and prohibitions (relating both to the company and its employees), and it should be bilingual.